SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-022974
Filing Date
2011-04-27
Accepted
2011-04-27 16:36:29
Documents
11
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a11-8833_110q.htm 10-Q 1539426
2 EX-31.1 a11-8833_1ex31d1.htm EX-31.1 13372
3 EX-31.2 a11-8833_1ex31d2.htm EX-31.2 13369
4 EX-32.1 a11-8833_1ex32d1.htm EX-32.1 6316
5 EX-32.2 a11-8833_1ex32d2.htm EX-32.2 6348
  Complete submission text file 0001104659-11-022974.txt   5899032

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tlcr-20110331.xml EX-101.INS 1026550
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tlcr-20110331.xsd EX-101.SCH 19686
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tlcr-20110331_cal.xml EX-101.CAL 33675
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tlcr-20110331_def.xml EX-101.DEF 62027
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tlcr-20110331_lab.xml EX-101.LAB 205583
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tlcr-20110331_pre.xml EX-101.PRE 99861
Mailing Address P.O. BOX 110526 RESEARCH TRIANGLE PARK NC 27709
Business Address 4101 RESEARCH COMMONS 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 919-316-6300
Talecris Biotherapeutics Holdings Corp. (Filer) CIK: 0001405197 (see all company filings)

IRS No.: 202533768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34473 | Film No.: 11784071
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1